Our research focuses on developing cutting-edge analytical sensors and detection techniques to identify trace amounts of pharmaceuticals, drugs, toxins, and their metabolites in bodily samples and fluids, such as fingerprints, saliva, urine, and more, directly at the point of care.
By designing highly selective nanomaterials that generate detectable and measurable signals within spectroscopy systems like Surface Enhanced Raman Spectroscopy (SERS) and Fluorescence Spectroscopy, or electrochemical systems such as cyclic voltammetry (CV) and square wave voltammetry (SWV), we are creating solutions that not only accelerate detection but also preserve the integrity of the sample.
Leveraging these technologies, our nanomaterial-based sensors provide rapid, accurate, and non-destructive analysis of target molecules. SERS enhances the Raman scattering signal of analytes, enabling highly sensitive detection even at extremely low concentrations.
Fluorescence spectroscopy aids in identifying specific molecular signatures, while electrochemical techniques like voltammetry offer real-time measurements of analyte concentrations.
The integration of these methods marks a significant advancement in analytical science, offering faster, on-site results with precise measurements. These breakthroughs have the potential to revolutionize fields from medical diagnostics to environmental monitoring, ensuring quicker and more accurate decision-making while preserving samples for further analysis.
Our research paves the way for accessible and reliable detection of harmful compounds, ultimately improving public health and safety.